Come up with a name for your new list and we'll add to it:
Genelux raised a round of funding on June 05, 2012. Investors include
AbbVie Biotech Ventures.
Genelux is a clinical stage biopharmaceutical company with a mission to change the way in which cancer is diagnosed and treated. The company has developed an oncolytic virus-based technology platform …